We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$46B
AUM Growth
-$5.82B
Cap. Flow
+$1.91B
Cap. Flow %
4.16%
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$127M
2
CI icon
Cigna
CI
+$54M
3
CVS icon
CVS Health
CVS
+$38.8M
4
MPC icon
Marathon Petroleum
MPC
+$28.9M
5
FANG icon
Diamondback Energy
FANG
+$19M

Sector Composition

Rank Sector Weight
1 Technology 16.95%
2 Financials 15.85%
3 Healthcare 14.41%
4 Consumer Discretionary 10.13%
5 Industrials 10.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DIS icon
26
Walt Disney
DIS
$172B
$291M 0.63%
2,651,048
-499
-0% -$56.7K
CMCSA icon
27
Comcast
CMCSA
$87.4B
$280M 0.61%
8,235,876
-4,819
-0.1% -$176K
BA icon
28
Boeing
BA
$167B
$278M 0.61%
863,218
-5,376
-0.6% -$1.86M
PEP icon
29
PepsiCo
PEP
$198B
$270M 0.59%
2,443,430
-12,516
-0.5% -$1.41M
MCD icon
30
McDonald's
MCD
$194B
$258M 0.56%
1,450,739
+20,039
+1% +$3.55M
WMT icon
31
Walmart Inc
WMT
$904B
$242M 0.53%
7,799,064
+101,505
+1% +$3.25M
ABT icon
32
Abbott
ABT
$191B
$231M 0.5%
3,200,097
+48,900
+2% +$3.44M
C icon
33
Citigroup
C
$215B
$220M 0.48%
4,229,690
-64,949
-2% -$4.11M
MDT icon
34
Medtronic
MDT
$113B
$217M 0.47%
2,387,191
+50,038
+2% +$4.68M
DD icon
35
DuPont de Nemours
DD
$18.4B
$217M 0.47%
1,599,601
+7,445
+0.5% +$1.07M
ORCL icon
36
Oracle
ORCL
$336B
$213M 0.46%
4,728,544
-248,434
-5% -$11.9M
ABBV icon
37
AbbVie
ABBV
$472B
$213M 0.46%
2,311,343
-9,131
-0.4% -$803K
MMM icon
38
3M
MMM
$92.5B
$203M 0.44%
1,272,080
-10,726
-0.8% -$1.78M
AMGN icon
39
Amgen
AMGN
$211B
$202M 0.44%
1,038,593
-129,554
-11% -$25.3M
NFLX icon
40
Netflix
NFLX
$303B
$190M 0.41%
7,099,520
+29,620
+0.4% +$886K
ADBE icon
41
Adobe
ADBE
$105B
$190M 0.41%
839,004
-228
-0% -$55K
IBM icon
42
IBM
IBM
$214B
$185M 0.4%
1,698,206
+5,683
+0.3% +$682K
LLY icon
43
Eli Lilly
LLY
$1.09T
$178M 0.39%
1,538,643
+12,962
+0.8% +$1.45M
AVGO icon
44
Broadcom
AVGO
$1.76T
$174M 0.38%
6,858,440
-215,220
-3% -$5.08M
UNP icon
45
Union Pacific
UNP
$173B
$174M 0.38%
1,261,607
-6,342
-0.5% -$940K
TXN icon
46
Texas Instruments
TXN
$246B
$167M 0.36%
1,766,166
-19,579
-1% -$1.9M
PM icon
47
Philip Morris
PM
$313B
$166M 0.36%
2,487,927
+40,456
+2% +$3.38M
PYPL icon
48
PayPal
PYPL
$50.3B
$166M 0.36%
1,973,019
-7,836
-0.4% -$653K
CRM icon
49
Salesforce
CRM
$155B
$165M 0.36%
1,203,950
+8,365
+0.7% +$1.15M
NKE icon
50
Nike
NKE
$63.2B
$164M 0.36%
2,207,640
-9,316
-0.4% -$697K

Similar funds

RhumbLine Advisers's Q4 2018 Portfolio in Review

As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.

  • RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
  • RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
  • RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
  • RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
  • RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
  • RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
  • RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.

Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.